• Newly Diagnosed1
• Recurrent1

• Protocols

• EAF223

  OPEN TO ACCRUAL

  Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial (GABLE)
  
  

• UW24143

  OPEN TO ACCRUAL

  P3 Open-Label Niraparib with Temozolomide in Newly-Diagnosed, MGMT Unmethlyated Glioblastoma